Key Financial Data Of Group

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7262351

Concept As at
2025-02-28
2024-03-01 to
2025-02-28
2024-03-01 to
2025-02-28
As at
2025-02-28
As at
2025-02-28
As at
2025-02-28
2023-03-01 to
2024-02-29
As at
2024-02-29
2023-03-01 to
2024-02-29
As at
2024-02-29
As at
2023-02-28
2022-03-01 to
2023-02-28
As at
2023-02-28
2022-03-01 to
2023-02-28
As at
2022-02-28
2021-03-01 to
2022-02-28
As at
2022-02-28
2021-03-01 to
2022-02-28
2020-03-01 to
2021-02-28
As at
2021-02-28
As at
2021-02-28
2020-03-01 to
2021-02-28
Key financial data of group
Business results of group
Net sales
102,618,000,000 JPY
156,006,000,000 JPY
141,706,000,000 JPY
96,647,000,000 JPY
128,330,000,000 JPY
92,979,000,000 JPY
120,193,000,000 JPY
90,585,000,000 JPY
114,510,000,000 JPY
86,694,000,000 JPY
Ordinary profit (loss)
16,511,000,000 JPY
24,010,000,000 JPY
19,649,000,000 JPY
14,226,000,000 JPY
16,051,000,000 JPY
14,057,000,000 JPY
12,638,000,000 JPY
10,608,000,000 JPY
11,829,000,000 JPY
10,372,000,000 JPY
Profit (loss) attributable to owners of parent
21,758,000,000 JPY
13,969,000,000 JPY
11,742,000,000 JPY
9,658,000,000 JPY
9,250,000,000 JPY
Comprehensive income
29,546,000,000 JPY
25,727,000,000 JPY
23,844,000,000 JPY
15,883,000,000 JPY
9,926,000,000 JPY
Net assets
208,618,000,000 JPY
279,407,000,000 JPY
267,082,000,000 JPY
212,829,000,000 JPY
258,408,000,000 JPY
214,501,000,000 JPY
254,885,000,000 JPY
222,355,000,000 JPY
253,809,000,000 JPY
231,247,000,000 JPY
Total assets
249,212,000,000 JPY
343,068,000,000 JPY
328,779,000,000 JPY
255,997,000,000 JPY
313,917,000,000 JPY
254,043,000,000 JPY
302,858,000,000 JPY
254,330,000,000 JPY
299,861,000,000 JPY
264,138,000,000 JPY
Net assets per share
2,852.47
3,788.47
3,492.62
2,804.37
3,294.20
2,754.67
3,171.83
2,784.39
3,083.98
2,825.43
Basic earnings (loss) per share
222.20
295.57
181.62
128.08
148.01
131.21
118.92
88.25
113.22
102.07
Diluted earnings per share
221.88
295.15
181.42
127.93
147.88
131.10
118.84
88.19
113.11
101.97
Equity-to-asset ratio
0.835 xbrli:pure
0.806 xbrli:pure
0.805 xbrli:pure
0.830 xbrli:pure
0.816 xbrli:pure
0.843 xbrli:pure
0.835 xbrli:pure
0.873 xbrli:pure
0.841 xbrli:pure
0.875 xbrli:pure
Rate of return on equity
0.078 xbrli:pure
0.080 xbrli:pure
0.054 xbrli:pure
0.046 xbrli:pure
0.047 xbrli:pure
0.048 xbrli:pure
0.038 xbrli:pure
0.032 xbrli:pure
0.037 xbrli:pure
0.037 xbrli:pure
Price-earnings ratio
19.0 xbrli:pure
14.3 xbrli:pure
21.3 xbrli:pure
30.2 xbrli:pure
25.8 xbrli:pure
29.1 xbrli:pure
30.8 xbrli:pure
41.5 xbrli:pure
58.6 xbrli:pure
65.1 xbrli:pure
Net cash provided by (used in) operating activities
18,765,000,000 JPY
18,188,000,000 JPY
12,727,000,000 JPY
19,199,000,000 JPY
5,289,000,000 JPY
Net cash provided by (used in) investing activities
17,563,000,000 JPY
-2,512,000,000 JPY
-23,868,000,000 JPY
-13,060,000,000 JPY
7,815,000,000 JPY
Net cash provided by (used in) financing activities
-15,850,000,000 JPY
-16,691,000,000 JPY
-14,687,000,000 JPY
-15,189,000,000 JPY
-7,187,000,000 JPY
Cash and cash equivalents
89,780,000,000 JPY
66,366,000,000 JPY
65,424,000,000 JPY
86,247,000,000 JPY
91,354,000,000 JPY
Number of employees
2,741 xbrli:pure
1,488 xbrli:pure
58 xbrli:pure
2,799 xbrli:pure
2,759 xbrli:pure
1,506 xbrli:pure
2,769 xbrli:pure
1,521 xbrli:pure
2,784 xbrli:pure
1,587 xbrli:pure
2,770 xbrli:pure
1,583 xbrli:pure
Average number of temporary employees
853 xbrli:pure
281 xbrli:pure
45 xbrli:pure
898 xbrli:pure
923 xbrli:pure
274 xbrli:pure
874 xbrli:pure
288 xbrli:pure
689 xbrli:pure
284 xbrli:pure
691 xbrli:pure
285 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.